Clinical indications expanded by FDA’s Emergency Guidance to enable more concise home-based ECG monitoring IRVINE, Calif., April 28, 2020 /PRNewswire/ — Coala Life, a world leading pioneer in remote and real-time cardiac monitoring solutions, today announces additional expansion of capabilities to help monitor patients from home. The expansion makes the Coala Heart Monitor […]
Other News
AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, includes existing investors Broadview Ventures and aMoon Fund as well as new investors Hatteras Venture Partners, Catalyst Health Ventures (CHV) and Longview Ventures, a Broadview affiliate. […]
Artio Medical Appoints Nathaniel Hagedorn to Board of Directors
Fairway, KS – April 28, 2020 – Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets today announced the appointment of entrepreneur and businessman Nathaniel Hagedorn to its Board of Directors. As the founder and CEO of NorthPoint Development, […]
LivaNova Bi-Flow Cannula Receives CE Mark for ECMO Applications
Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned CE Mark approval for ECMO procedures where femoral artery cannulation can be applied. Bi-Flow previously received CE […]
Merit Medical Reports Earnings for Quarter Ended March 31, 2020, Withdraws FY 2020 Guidance
* Core revenue on a constant currency basis, non-GAAP EPS, non-GAAP net income, non-GAAP operating margin, non-GAAP gross margin and free cash flow are non-GAAP financial measures. A reconciliation of these and other non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures is included under […]
iRhythm Technologies Announces the Appointment of Renee Budig to its Board of Directors
SAN FRANCISCO, April 23, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the appointment of Renee Budig to its Board of Directors effective April 23, 2020. Ms. Budig was appointed as a Class II […]
Edwards Lifesciences Reports First Quarter Results
IRVINE, Calif., April 23, 2020 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended March 31, 2020. First Quarter Results and Outlook Sales grew nearly 14% to $1.1 billion TAVR sales grew 24%; underlying1 sales grew 25% […]
Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment
WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular, a developer of serration technology for vessel dilatation in cardiovascular disease interventions, announces FDA 510(k) Clearance of its Serranator® PTA Serration Balloon Catheter for treating below-the-knee (BTK) lesions. The Serranator device is the first and only angioplasty balloon FDA Cleared and CE Marked that embeds serration technology into a […]
CHF Solutions Ships First Commercial Orders of Aquadex SmartFlow™ system to Austria
EDEN PRAIRIE, Minn., April 23, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped the first commercial orders of its next generation Aquadex SmartFlow™ system to Austria, following shipments to […]
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
BASKING RIDGE, N.J., April 23, 2020 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, cardiovascular disease, today announced that it has entered into definitive agreements with several institutional and accredited […]



